NCT00733915

Brief Summary

The main objective of this study is to evaluate how the LCS Complete mobile-bearing total knee system and surgical instrumentation performs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
241

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Mar 2002

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2002

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2007

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

August 11, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 13, 2008

Completed
6.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2014

Completed
Last Updated

September 12, 2025

Status Verified

September 1, 2025

Enrollment Period

5.5 years

First QC Date

August 11, 2008

Last Update Submit

September 11, 2025

Conditions

Keywords

Arthroplasty, knee, TKA, TKR, Duofix, Porocoat, LCS

Outcome Measures

Primary Outcomes (1)

  • To demonstrate the surgical performance of the LCS Complete mobile-bearing total knee system and instrumentation using radiographic and intra-operative assessment

    10 years

Secondary Outcomes (1)

  • To demonstrate the survivorship and performance of the LCS Complete mobile-bearing total knee system using the American Knee Society clinical and radiographic assessment, Oxford Knee Score, SF12 and survivorship analysis.

    Pre surgery, surgery, 3 month, 1, 3, 5 and 10 years

Study Arms (1)

Single arm

EXPERIMENTAL

Cohort of total knee replacements with LCS Complete knee implants

Device: L.C.S. Complete Knee (DePuy Low Contact Stress Complete Knee System)

Interventions

L.C.S. Complete mobile-bearing total knee system

Single arm

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female subjects.
  • Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained
  • Subjects who, in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.
  • Subjects who present with idiopathic osteoarthritis, rheumatoid arthritis, post traumatic arthritis or any other pathology that in the opinion of the clinical investigator requires a primary total knee arthroplasty and who are considered suitable for treatment with a mobile bearing knee system (LCS Complete).
  • Subjects who in the opinion of the Clinical Investigator are considered to be suitable for treatment with the investigation device, according to the indications specified in the package insert leaflet.

You may not qualify if:

  • Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this study.
  • Subjects with a known history of poor compliance to medical treatment.
  • Women who are pregnant.
  • Subjects who are known drug or alcohol abusers or with psychological disorders that could effect follow-up care or treatment outcomes.
  • Subjects involved in Medical-Legal claims.
  • Subjects who have participated in a clinical study with an investigational product in the last month.
  • Subjects who are currently involved in any injury litigation claims.
  • Revision of an existing knee implant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Musgrave Park Hospital

Belfast, BT9 7JB, Ireland

Location

MeSH Terms

Conditions

Aagenaes syndrome

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 11, 2008

First Posted

August 13, 2008

Study Start

March 1, 2002

Primary Completion

September 1, 2007

Study Completion

October 1, 2014

Last Updated

September 12, 2025

Record last verified: 2025-09

Locations